Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Greenworks
301260
5
Tuoxin Pharmaceutical Group
301089
CN Stock MarketDetailed Quotes
603858 Shandong Buchang Pharmaceuticals
- 16.07
- +0.18+1.13%
Trading May 16 14:36 CST
17.77BMarket Cap-49.29P/E (TTM)
16.10High15.90Low49.76KlotVolume15.98Open15.89Pre Close79.59MTurnover0.45%Turnover RatioLossP/E (Static)1.11BShares19.7052wk High1.70P/B17.77BFloat Cap13.8352wk Low17.48Limit Up1.11BShs Float86.04Historical High14.30Limit Down1.26%Amplitude13.36Historical Low0.13Dividend TTM16.00Avg Price22.19KlotAsk0.78%Div YieldTTM100Lot Size26.55KlotBid
Shandong Buchang Pharmaceuticals Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 10.57%2.93B | -11.71%11.71B | -15.01%8.58B | -16.55%5.77B | -20.05%2.65B | -14.40%13.26B | -13.37%10.09B | -7.82%6.92B | -2.48%3.31B | -4.22%15.49B |
| Refunds of taxes and levies | ---- | -79.19%3.52M | -71.55%2.9M | 141.53%2.64M | -90.37%12.48K | -91.64%16.92M | -94.64%10.21M | -99.38%1.09M | --129.6K | 41,651.50%202.42M |
| Cash received relating to other operating activities | -36.81%63.14M | -47.55%46.75M | 2.52%203.17M | -59.59%76.7M | 2.35%99.93M | 9.42%89.12M | -24.61%198.19M | 8.25%189.79M | -26.38%97.64M | -77.62%81.45M |
| Cash inflows from operating activities | 8.85%2.99B | -12.03%11.76B | -14.73%8.78B | -17.67%5.85B | -19.41%2.75B | -15.27%13.36B | -14.90%10.3B | -9.53%7.11B | -3.37%3.41B | -4.62%15.77B |
| Goods services cash paid | -17.26%526.85M | -29.43%2.86B | -34.97%1.97B | -7.27%1.34B | -13.07%636.79M | 51.39%4.05B | 69.04%3.03B | 29.69%1.44B | 34.54%732.54M | -22.24%2.68B |
| Staff behalf paid | -9.39%241.72M | -1.54%1.03B | -3.54%792.34M | -1.78%520.55M | -1.81%266.77M | 6.13%1.05B | 6.87%821.44M | 7.02%530.01M | 12.19%271.68M | 6.96%989.3M |
| All taxes paid | -26.78%364.15M | -22.52%1.42B | -30.39%1.05B | -35.09%742.59M | -16.94%497.3M | -13.30%1.84B | -2.76%1.51B | -4.71%1.14B | 7.03%598.7M | -8.28%2.12B |
| Cash paid relating to other operating activities | -7.25%1.18B | -16.93%5.5B | -20.24%4.27B | -26.03%2.76B | -32.77%1.27B | -8.47%6.62B | -6.29%5.35B | 2.78%3.73B | 4.75%1.9B | -15.30%7.23B |
| Adjustment items of operating cash outflws | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from operating activities | -13.48%2.31B | -20.23%10.82B | -24.55%8.08B | -21.72%5.36B | -23.53%2.68B | 4.17%13.56B | 9.03%10.71B | 6.35%6.84B | 10.87%3.5B | -14.45%13.02B |
| Net cash flows from operating activities | 814.82%678.02M | 580.53%939.95M | 270.34%701.46M | 85.62%497.2M | 185.18%74.11M | -107.10%-195.61M | -118.08%-411.8M | -81.21%267.86M | -123.21%-87.01M | 108.68%2.76B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | ---- | ---- | --400M | --380M | ---- | ---- | ---- |
| Cash received from returns on investments | --1.25M | -74.78%2.97M | -80.88%2.43M | ---- | ---- | 8.43%11.78M | 52.45%12.71M | 114.15%9.32M | 477.80%11.85M | -86.17%10.86M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 647.21%92.36K | -79.51%491.7K | -77.58%403.61K | -82.20%40.86K | -49.74%12.36K | 395.63%2.4M | 883.35%1.8M | 88.85%229.55K | -72.86%24.59K | -66.63%484.24K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | --431.69 | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | 70.10%1.55M | -61.49%7.54M | -71.98%5.31M | -98.86%3.58M | -87.73%909.07K | -1.99%19.57M | 34.85%18.95M | 3,700.28%312.94M | 142.66%7.41M | -5.54%19.97M |
| Cash inflows from investing activities | 213.47%2.89M | -97.46%11M | -98.03%8.14M | -98.88%3.62M | -95.22%921.87K | 1,285.27%433.75M | 1,731.67%413.46M | 2,437.27%322.49M | 271.21%19.28M | -69.03%31.31M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -57.08%37.48M | -62.83%197M | -51.05%188.98M | -46.18%134.15M | -0.40%87.33M | -2.44%529.92M | 5.81%386.06M | -4.06%249.28M | -42.39%87.68M | 25.29%543.17M |
| Cash paid to acquire investments | --302.2M | -11.28%63.55M | -79.63%13.75M | -54.17%13.75M | ---- | -85.04%71.63M | -91.00%67.5M | 13.36%30M | --250M | 848.29%478.96M |
| Cash paid relating to other investing activities | ---- | -98.50%3K | ---- | ---- | ---- | -98.96%200.58K | -98.45%200.15K | --200.15K | ---- | -92.27%19.36M |
| Cash outflows from investing activities | 288.97%339.68M | -56.70%260.55M | -55.32%202.73M | -47.08%147.9M | -74.14%87.33M | -42.22%601.75M | -59.77%453.76M | -2.38%279.48M | 121.88%337.68M | 37.62%1.04B |
| Net cash flows from investing activities | -289.78%-336.79M | -48.54%-249.55M | -382.86%-194.59M | -435.41%-144.28M | 72.86%-86.4M | 83.37%-168M | 96.35%-40.3M | 115.72%43.01M | -116.61%-318.4M | -54.07%-1.01B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -37.88%1.37M | 387.15%20.89M | 1,267.76%20.79M | 3,295.00%6.79M | 1,000.00%2.2M | 40.14%4.29M | -49.75%1.52M | -92.08%200K | -92.08%200K | -39.06%3.06M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | -37.88%1.37M | 387.15%20.89M | 1,267.76%20.79M | 3,295.00%6.79M | 1,000.00%2.2M | 40.14%4.29M | -49.75%1.52M | -92.08%200K | -92.08%200K | -39.06%3.06M |
| Cash from borrowing | -34.12%624M | 58.45%2.31B | 45.27%1.95B | 46.50%1.5B | 99.41%947.21M | -31.18%1.46B | -20.27%1.34B | -26.43%1.02B | -57.29%475M | -33.35%2.11B |
| Cash received relating to other financing activities | 6,048.66%58.03M | -96.43%1.88M | -48.70%952.25K | -94.37%954.66K | -98.57%943.76K | -73.57%52.57M | -98.30%1.86M | 32.58%16.97M | 443.32%66.16M | 2,481.49%198.87M |
| Cash inflows from financing activities | -28.09%683.4M | 54.00%2.33B | 46.52%1.97B | 44.83%1.5B | 75.55%950.36M | -34.73%1.51B | -25.07%1.35B | -26.01%1.04B | -51.96%541.36M | -27.27%2.32B |
| Borrowing repayment | -24.38%309.98M | 39.28%1.81B | 2.46%1.3B | -7.29%767.31M | -31.73%409.9M | -52.04%1.3B | -36.73%1.27B | -45.41%827.65M | -49.72%600.39M | -13.71%2.71B |
| Dividend interest payment | -10.92%29.78M | -76.31%287.18M | -78.61%252.67M | 22.37%69.19M | 9.61%33.43M | 116.04%1.21B | 116.51%1.18B | -41.98%56.54M | -22.77%30.5M | -27.72%561.17M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | -18.52%14.74M | -21.89%13.65M | ---- | ---- | 30.79%18.1M | 29.94%17.48M | ---- | ---- | -54.10%13.84M |
| Cash payments relating to other financing activities | -58.99%71.57M | 1,075.42%800.13M | 597.17%665.75M | 309.29%452.72M | 290.48%174.53M | 77.98%68.07M | -15.41%95.49M | 107.43%110.61M | 572.24%44.7M | -16.14%38.25M |
| Cash outflows from financing activities | -33.43%411.33M | 12.28%2.89B | -12.86%2.22B | 29.60%1.29B | -8.54%617.86M | -21.99%2.58B | -4.38%2.54B | -40.32%994.8M | -45.52%675.59M | -16.48%3.3B |
| Net cash flows from financing activities | -18.17%272.07M | 46.95%-565.21M | 79.76%-241.9M | 387.82%215.49M | 347.71%332.5M | -7.88%-1.07B | -38.78%-1.2B | 116.83%44.17M | -18.44%-134.23M | -28.11%-987.57M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -98.03%-42.16K | 8.30%10.65K | -113.15%-2.4K | -77.78%4.58K | -65.65%-21.29K | -93.89%9.83K | -89.48%18.29K | -29.32%20.6K | -137.42%-12.85K | 146.89%161.06K |
| Adjustment items effecting cash and cash equivalents | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- |
| Net increase in cash and cash equivalents | 91.53%613.25M | 108.76%125.2M | 116.08%264.97M | 60.08%568.42M | 159.33%320.18M | -288.51%-1.43B | -628.80%-1.65B | -60.06%355.07M | -570.80%-539.65M | 812.56%758.04M |
| Add:Begin period cash and cash equivalents | 18.21%817.53M | -67.36%692.33M | -67.36%692.33M | -67.36%692.33M | -67.40%691.59M | 55.60%2.12B | 55.60%2.12B | 55.60%2.12B | 55.60%2.12B | -7.24%1.36B |
| End period cash equivalent | 41.41%1.43B | 18.08%817.53M | 102.04%957.3M | -49.09%1.26B | -36.03%1.01B | -67.36%692.33M | -71.71%473.82M | 9.94%2.48B | 7.02%1.58B | 55.60%2.12B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting